financetom
Business
financetom
/
Business
/
Fox CEO expects new streaming service to attract users in mid-single-digit millions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fox CEO expects new streaming service to attract users in mid-single-digit millions
Mar 3, 2025 11:03 AM

March 3 (Reuters) - Fox Corp's ( FOXA ) upcoming subscription streaming service is

expected to draw subscribers in the mid-single-digit millions range, CEO Lachlan Murdoch said on

Monday at the Morgan Stanley Technology, Media & Telecom Conference.

Fox is planning to launch the yet-to-be-named service by the end of 2025 to diversify its

revenue streams and attract an audience outside its flagship cable television business.

Media giants across the United States are experiencing a paradigm shift as more people cut

the cord in favor of online streaming platforms that provide on-demand video.

"We think the traditional cable bundle has been the greatest value and service to consumers

in this country, and it continues to be in a critical and important part," Murdoch said.

He said that the company is expecting to launch the service around the next NFL season in

the fall.

The company named former Apple TV+ executive Pete Distad as the CEO of the upcoming

streaming venture.

Murdoch said Fox Nation, a streaming platform associated with Fox News Channel, has grown

with strength from programming such as documentary series backed by director Martin Scorsese.

The service has drawn between 2 million and 2.5 million subscribers, Murdoch said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Montrose Environmental Acquires Canada-based Paragon Soil & Environmental Consulting
Montrose Environmental Acquires Canada-based Paragon Soil & Environmental Consulting
Jun 5, 2024
08:25 AM EDT, 06/05/2024 (MT Newswires) -- Montrose Environmental Group ( MEG ) said Wednesday that it has acquired Paragon Soil & Environmental Consulting, a Canada-based environmental consulting firm. Financial terms of the deal were not disclosed. Price: 43.54, Change: -0.43, Percent Change: -0.98 ...
Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories
Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories
Jun 5, 2024
08:27 AM EDT, 06/05/2024 (MT Newswires) -- Axsome Therapeutics ( AXSM ) said Wednesday it has settled patent litigation with Unichem Laboratories regarding Axsome's sleep disorder drug Sunosi. The pharmaceutical company said the litigation, pending in the United States District Court for the District of New Jersey, arose after Unichem applied for the US Food and Drug Administration's approval to...
Calibre Reports Additional Gold Mineralization at Valentine Gold Mine Complex in Newfoundland & Labrador
Calibre Reports Additional Gold Mineralization at Valentine Gold Mine Complex in Newfoundland & Labrador
Jun 5, 2024
08:26 AM EDT, 06/05/2024 (MT Newswires) -- Calibre (CXB.TO), which lost 4% yesterday, on Wednesday highlighted drill results from its 2024 exploration program within its 250-square-kilometer Valentine Gold Mine complex in Newfoundland & Labrador, Canada. Among the highlights, the company reported 2.25 g/t of gold over 15.30 meters estimated true width, including 24.68 g/t of gold over 0.85 meters estimated...
Mind Medicine Shares Fall After FDA Committee Votes Against Lykos Therapeutics' Psychedelic Drug
Mind Medicine Shares Fall After FDA Committee Votes Against Lykos Therapeutics' Psychedelic Drug
Jun 5, 2024
08:25 AM EDT, 06/05/2024 (MT Newswires) -- Mind Medicine's (MNMD) shares were down 9% in Wednesday's premarket activity, a day after advisers to the US Food and Drug Administration voted against Lykos Therapeutics' psychedelic drug. Lykos Therapeutics said late Tuesday that advisers to the US Food and Drug Administration have voted against its therapy based on the mind-altering drug midomafetamine,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved